Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMPA versus GnRH analogue for premenopausal women with uterine fibroids
ChiCTR-IPR-15007056Phase 4Not yet recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 1990
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of medroxyprogesterone acetate in Fibromyoma (LM) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoints: Treatment efficacy based on menstrual flow, PBAC-defined treatment success and 1 more. Planned start Jan 1990; status: not yet recruiting.
02
Drugs
medroxyprogesterone acetate
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ChiCTR-IPR-15007056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007056.